• Explore /
  • Poster
  • / Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses of diabetic patients from the phase II CHRONOS-1 study.

Copanlisib treatment in patients with relapsed or refractory indolent B-cell lymphoma: Subgroup analyses of diabetic patients from the phase II CHRONOS-1 study.

Abstract Poster

Authors

Martin Dreyling

Martin H. Dreyling

Klinikum der Universität München LMU, Medizinische Klinik und Poliklinik III, Munich, Germany

Martin H. Dreyling , Sirpa Leppa , Terrance Comeau , Marina Kosinova , Georg Lenz , Arnon Nagler , Dae Seog Heo , Sung Yong Oh , Liping Huang , Oliver Wirtz , Ashok Miriyala , Jose E. Garcia-Vargas , Barrett H. Childs , Pier Luigi Zinzani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

NCT01660451

Citation

J Clin Oncol 36, 2018 (suppl; abstr 7570)

DOI

10.1200/JCO.2018.36.15_suppl.7570

Abstract #

7570

Poster Bd #

207

Abstract Disclosures

Similar Posters

First Author: Martin H. Dreyling

First Author: J. Szymonifka

First Author: Cyrille Touzeau

First Author: Philippe Armand